FindTrial
Sign In

Clinical interventional study to evaluate the efficacy of Gud-Pippalimool tablet and Ashwagandha tablet in the management of Nidranash in Healthy Volunteers (Patients)

Comparative clinical study to evaluate the efficacy of Gud-Pippalimool tablet and Ashwagandha tablet in the management of Nidranash w.r.t Insomnia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083928
Enrollment
100
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G968- Other specified disorders of central nervous system

Interventions

None listed

Sponsors

Dr Tanya Bhawnani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-Patients complaining of difficulty in falling asleep, frequent or sustained awakenings and early morning awakenings. 2-patients suffering from insomnia from one month or above.

Exclusion criteria

Exclusion criteria: 1-Patients with major psychiatric illness like schizophrenia, depressive psychosis, epilepsy, etc 2-Patients with drug dependency. 3-Women in their pregnancy and lactation. 4-Chronic alcoholic patients. 5-Diabetic patients.

Design outcomes

Primary

MeasureTime frame
The drug may help to bring Improvement in sleep Quality and durationTimepoint: total 28 days study Follow up on 14th day 28th day & 14 days after the completion of treatment.—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDr Dnyaneshwar M Padavi

Padmashree Dr DY Patil School of Ayurveda , Nerul ,Navi Mumbai

drtanyabhawnani@gmail.com7805913223

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026